Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
CDKN2A overexpression
i
Other names:
CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Associations
(4)
News
Trials
C3 | Sensitive
D | Sensitive
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
PARP Inhibitors
Cyclin Dependent Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
CD Protein Inhibitors
BCL Inhibitors
Cancel
Soft Tissue Sarcoma
Ovarian Cancer
Mantle Cell Lymphoma
Estrogen Receptor Positive Breast Cancer
olaparib
C3
CDKN2A overexpression
|
Soft Tissue Sarcoma
|
olaparib
palbociclib
D
CDKN2A overexpression
|
Ovarian Cancer
|
palbociclib
venetoclax
D
CDKN2A overexpression
|
Mantle Cell Lymphoma
|
venetoclax
CDK4 inhibitor + CDK6 inhibitor
D
CDKN2A overexpression
|
Estrogen Receptor Positive Breast Cancer
|
CDK4 inhibitor + CDK6 inhibitor
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
